HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Coronary Occlusion

Complete blockage of blood flow through one of the CORONARY ARTERIES, usually from CORONARY ATHEROSCLEROSIS.
Also Known As:
Coronary Occlusions; Occlusion, Coronary; Occlusions, Coronary
Networked: 2967 relevant articles (136 outcomes, 274 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Infarction (Infarctions)
2. Myocardial Infarction
3. Ischemia
4. Myocardial Ischemia (Ischemic Heart Diseases)
5. Ventricular Fibrillation

Experts

1. Bolli, Roberto: 26 articles (03/2021 - 01/2002)
2. Guo, Yiru: 19 articles (03/2021 - 01/2002)
3. Werner, Gerald S: 18 articles (01/2022 - 07/2003)
4. Maslov, L N: 17 articles (07/2017 - 06/2001)
5. Warltier, David C: 16 articles (02/2009 - 03/2002)
6. Dawn, Buddhadeb: 14 articles (11/2011 - 08/2002)
7. Kersten, Judy R: 14 articles (02/2009 - 03/2002)
8. Pagel, Paul S: 13 articles (08/2006 - 03/2002)
9. Suttorp, Maarten J: 12 articles (01/2021 - 05/2004)
10. Inserte, Javier: 11 articles (07/2021 - 09/2002)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Coronary Occlusion:
1. Nifedipine (Adalat)FDA LinkGeneric
2. Propranolol (Inderal)FDA LinkGeneric
3. Verapamil (Calan)FDA LinkGeneric
4. Nitroglycerin (Dynamite)FDA LinkGeneric
5. Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
6. Sirolimus (Rapamycin)FDA Link
7. MetalsIBA
8. Adenosine (Adenocard)FDA LinkGeneric
9. Nicorandil (SG 75)IBA
10. Cardioplegic SolutionsIBA
10/01/1988 - "This study was conducted to assess the protective effects of antegrade infusion of cardioplegic solution with simultaneously controlled coronary sinus occlusion on regionally ischemic myocardium after acute coronary occlusion and reperfusion. "
07/01/1997 - "This study was done to determine whether retrograde delivery of cardioplegic solution provides uniform blood flow to the myocardium supplied by an occluded coronary artery and whether it maintains myocardial energy levels beyond the coronary occlusion. "
01/01/1993 - "We conclude that in the presence of an acute coronary occlusion with ischemic myocardium, warm blood cardioplegic solution should be given in a continuous retrograde fashion and does not result in myocardial protection superior to the protection that can be achieved with antegrade/retrograde cold blood cardioplegic solution."
08/01/1989 - "This study was undertaken to determine whether topical hypothermia is necessary for optimal myocardial protection when distribution of the cardioplegic solution is heterogeneous because of coronary occlusions. "
07/01/1997 - "First, retrograde delivery of cardioplegic solution provides sufficient flow to the myocardium beyond a coronary occlusion to maintain near normal levels of energy metabolites, and second, the efficacy of the retrograde route of cardioplegic solution delivery (in terms of distribution of the solution and rate of myocardial energy recovery) is significantly lower than that of the antegrade route."

Therapies and Procedures

1. Stents
2. Therapeutics
3. Catheters
4. Drug-Eluting Stents
5. Thrombolytic Therapy